Treatment Deintensification for Human Papillomavirus-Associated Oropharyngeal Cancer

2017/08/10 by Demetri Arnaoutakis, Baran D. Sumer · 1 citation
Medicine · #Cancer Diagnosis and Treatment #Head and Neck Cancer Studies #Head and Neck Surgical Oncology

paper · pdf · doi:10.1245/s10434-017-6045-6

crossref issued 2017/08/10 · crossref published 2017/08/10 · crossref published-online 2017/08/10 · openalex publication_date 2017/08/10 · crossref created 2017/08/10 · crossref published-print 2017/11/01 · crossref deposited 2019/10/02 · crossref indexed 2022/04/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/29

Citations

• Combined radiation therapy and surgery in the management of advanced head and neck cancer: Final report of study 73–03 of the radiation therapy oncology group
• Comprehensive genomic characterization of head and neck squamous cell carcinomas
• Long-term Follow-up of the RTOG 9501/Intergroup Phase III Trial: Postoperative Concurrent Radiation Therapy and Chemotherapy in High-Risk Squamous Cell Carcinoma of the Head and Neck
• Evaluation of the dose for postoperative radiation therapy of head and neck cancer: First report of a prospective randomized trial
• Transoral laser microsurgery as primary treatment for advanced‐stage oropharyngeal cancer: A united states multicenter study
• Transoral resection of tonsillar squamous cell carcinoma
• Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
• Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)
• Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
• Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
• Transoral Laser Microsurgery for Squamous Cell Carcinoma of the Base of the Tongue
• E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx— ECOG-ACRIN Cancer Research Group

Cited by

• HPV-positive oropharyngeal cancer [wikipedia]